Member Info for Notposting

I will continue to discuss this topic as I see fit or enjoy. It’s clear that many people are either unaware of the facts, despite claims to the contrary, or, if they are aware, are intentionally misleading others.

And just to correct you, there is no “full clearance” as you put it. That is a misleading statement, but I do not expect the others to correct it, as it does not suit their narrative.

No, because he is actually a scientist, and your comments are incorrect as it isn’t as simple as that. He will also know that signals from one to three patients are far too limited to draw any meaningful conclusions. They are based solely on standard testing and could easily be false positives or patient-specific outcomes in some cases (not saying it’s the case here, but generally)

He is also unlikely to be emotionally invested in the share price, and far more focused on the scientific end point therefore far more detached from commentary for short term share price impact unlike some here.

There is no “try”. I’ve made my points, which are correct.

TheGutts, comprehension clearly is not your strength. It is immediate relative to 2026 if the events occur back to back, which they effectively would be. It is hardly a “narrative” when I am simply pointing out a fact. And correct, it does matter, as its view. Honestly, give me strength.

Again, Digitt, your response doesn’t surprise me. Manipulative at best sadly, but that’s been the common theme for some time.

TraderRicky. Respectfully, none of us “know” anything for certain at this stage. The company is still in clinical trials, just as your “special friend” continually reminds everyone.

However, the concerns raised by the so-called “trolls” have proven accurate time and again when judged purely by the share price and the unfolding financial reality. Their warnings have saved some investors from getting caught up in hype and watching significant profits evaporate, especially while others were confidently predicting £20, £30, even £40 per share on very little substantive basis.

The facts are straightforward: there’s a £5.6 million funding gap by January, followed by an immediate requirement for an additional £10 million. Even under a best-case scenario stretching into 2027/28, the company will still need substantial capital. Unless a major breakthrough or miracle occurs, significant dilution is almost inevitable as the longer it remains outstanding the less likely it will be on favourable terms.

There’s at least one on here soon to find out.

You should start a horse tips WhatsApp group 😉

Did a special friend give it to you?

JustHereForFleecing. credit where it’s due. That’s a sensible post for once, without any misleading statements, and it also highlights that Haywain wasn’t quite accurate in his earlier claim.

Caveat: we don’t know if all three are still alive. The statistics are slightly off, and there’s no obligation to report such events to the market, i.e., shareholders, if they’ve sadly passed.

You’ll likely find there is no £300k buyer and it’s a transfer and whilst it could be a worked order, unlikely given the lack of support 🙂

You mean the one that was proven to be taken out of context and not doctored at all? Ahh yes.

Except that is not supported by publicly available data 🫠

Well done, Pumpy!

“ his initial seed investors persuaded him to do a RTO on the London Stock Exchange, he accepted.”

Just make a story up as he goes. 😆

How did that go for you?

SHUFF05

Posted in: HEMO

Posts: 353

RE: Closing Price £10.10 +10% 👍🍷12 Sep 2025 16:53

Be interesting to see what that 50k Kipper is worth close Tuesday. Minimum 75k my guess. Good luck all

“Vlad IS ATTENDING and **has meetings lined up.**”

“Just look at the 59k BUY after hours.”

😄😄😄 LOL

Enjoy Pumpky 😄

“No first in human CAR-T with any demonstrable efficacy has ever sold for less than 100M”

You don’t have “demonstrable efficacy”. You have positive indications against standard testing.

No intention to engage further. It is evident that you are part of the same group and, sadly, conducting yourself in the same manner.